Medicofarma Biotech Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	29	27	26	74	79	116
Market Cap Growth	67.19%	2.83%	-64.24%	-6.06%	-32.05%	483.23%
Enterprise Value	33	30	28	74	78	115
Last Close Price	0.43	0.40	0.39	1.08	1.16	1.70
PS Ratio	242.66	226.22	21.53	98.24	18.46	34.63
PB Ratio	5.12	4.77	3.84	8.04	6.22	8.14
P/TBV Ratio	5.16	4.81	3.89	8.17	7.09	9.46
P/OCF Ratio	-	-	-	10167.70	81.76	63.64
EV/Sales Ratio	273.57	253.67	23.08	98.22	18.26	34.60
EV/EBITDA Ratio	-	-	-	-	451.82	173.24
Debt / Equity Ratio	0.65	0.65	0.37	0.15	-	-
Net Debt / Equity Ratio	0.65	0.65	0.37	0.15	-0.04	0.00
Net Debt / EBITDA Ratio	-17.80	-17.80	-4.81	-2.53	-2.95	-0.12
Net Debt / FCF Ratio	-3.77	-3.77	-2.48	-1.26	2.05	0.16
Asset Turnover	0.01	0.01	0.08	0.05	0.26	0.39
Inventory Turnover	-	-	768.33	13.21	10.67	6.77
Quick Ratio	1.25	1.25	0.85	0.63	0.65	0.73
Current Ratio	1.25	1.25	0.85	0.63	0.69	1.00
Return on Equity (ROE)	-35.52%	-35.52%	-28.67%	-31.57%	-11.85%	-3.08%
Return on Assets (ROA)	-7.35%	-7.35%	-8.73%	-10.50%	-5.95%	-2.07%
Return on Invested Capital (ROIC)	-19.51%	-18.10%	-20.78%	-21.88%	-12.02%	-4.00%
Return on Capital Employed (ROCE)	-16.80%	-16.80%	-20.30%	-24.00%	-12.00%	-1.90%
Earnings Yield	-7.67%	-8.22%	-8.72%	-4.66%	-2.02%	-0.19%
FCF Yield	-	-3.63%	-3.86%	-1.49%	-0.32%	-0.42%
Buyback Yield / Dilution	-	-	-	-	-	-901.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.